Table 1

Title: Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Scope: use of infused umbilical cord mesenchymal stem cells to repair tissue damage in patients with pneumonia

Title: Treatment with Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Scope: use of infused mesenchymal stem cells to repair tissue damage in patients with pneumonia

Title: A Clinical Study to Investigate the Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients with Coronavirus Disease 2019 (COVID-19)

Scope: use of T89 (Dantonic) in patients with COVID-19

Title: Recombinant Human Angiotensin-Converting Enzyme 2 (rhACE2) as a Treatment for Patients with COVID-19

Scope: delivery of rhACE2 to regulate damage mediated by its downregulation by SARS-CoV-2 infection

Title: Bevacizumab in Severe or Critical Patients with COVID-19 Pneumonia

Scope: use of bevacizumab (Avastin) in patients with COVID-19

Title: Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined with Standard Treatment in Patients with Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Scope: treatment of patients with COVID-19 with bromhexine hydrochloride, umifenovir hydrochloride, recombinant human interferon-α2b and favipiravir

Title: Adaptive COVID-19 Treatment Trial

Scope: remdesivir treatment of patients with COVID-19

Title: Clinical Study for Infusing Convalescent Plasma to Treat Patients with New Coronavirus Pneumonia (COVID-19)

Scope: infusion of polyclonal antibodies derived from immune plasma from convalescent patients with COVID-19

Title: The Efficacy and Safety of Carrimycin Treatment in Patients with Novel Coronavirus Infectious Disease (COVID-19): A Multicenter, Randomized, Open Label Controlled Study

Scope: a multicentre, randomized (1:1), open-controlled (one of lopinavir/ritonavir tablets or umifenovir or chloroquine phosphate) study

Title: An Open, Controlled Clinical Trial for Evaluation of Ganovo Combined with Ritonavir and Integrated Traditional Chinese and Western Medicine in the Treatment of Novel Coronavirus Infection (COVID-19)

Scope: use of danoprevir (Ganovo), a macrocyclic peptidomimetic inhibitor of HCV protease, in patients with COVID-19

Title: Efficacy of Therapeutic Effects of Hydroxychloroquine in Novel Coronavirus Pneumonia (COVID-19) Patients. Randomized Open-Label Controlled Clinical Trial

Scope: use of hydroxychloroquine to test its antiviral and anti-inflammatory effects in patients with COVID-19

Title: Therapeutic Effect of Hydroxychloroquine on Novel Coronavirus Pneumonia (COVID-19)

Scope: use of hydroxychloroquine to test its antiviral and anti-inflammatory effects in patients with COVID-19

Title: Efficacy and Safety of Corticosteroids in COVID-19

Scope: multicentre study analysing the effect of methylprednisolone at a dosage of 1mgkg⁻¹ per day for 7 days in patients with COVID-19

Title: Fingolimod in COVID-19

Scope: use of fingolimod, a sphingosine 1-phosphate receptor modulator, in patients with COVID-19

Title: The Efficacy and Safety of Thalidomide Combined with Low-Dose Hormones in the Treatment of Severe COVID-19

Scope: testing the anti-inflammatory effects of thalidomide in combination with methylprednisolone in patients with COVID-19-induced pneumonia

Title: Eculizumab (Soliris) in Covid-19 Infected Patients

Scope: testing the efficacy of the complement C5 inhibitor eculizumab in patients with COVID-19

Title: The Efficacy and Safety of Huaier in the Adjuvant Treatment of COVID-19

Scope: testing the anti-inflammatory effects of an extract of Trametes robiniophila Murr (Huaier) in patients with COVID-19

Title: Efficacy and Safety of Xue-Bi-Jing Injection in the Treatment of Severe Cases of Novel Coronavirus Pneumonia (COVID-19)

Scope: analysing the anti-inflammatory effects of an extract from Salvia miltiorrhiza (Chinese red sage) on patients with COVID-19

Title: Efficacy and Safety of Honeysuckle Oral Liquid in the Treatment of Novel Coronavirus Pneumonia (COVID-19)

Scope: a multicentre, randomized, controlled, open clinical trial aimed at analysing the impact of honeysuckle oral liquid on boosting immunity against COVID-19

Title: A Randomized, Open and Controlled Clinical Trial for Traditional Chinese Medicine in the Treatment of Novel Coronavirus Pneumonia (COVID-19)

Scope: no information available